CYDY - CytoDyn out-licenses U.S. rights to leronlimab for HIV for up to $87.5M December, 17 2019 05:03 PM CytoDyn Inc CytoDyn (OTCQB:CYDY) inks an agreement with privately held Vyera Pharmaceuticals related to HIV med leronlimab.More news on: CytoDyn Inc., Healthcare stocks news, Read more ...